|Bid||25.66 x 100|
|Ask||25.74 x 100|
|Day's Range||25.51 - 25.95|
|52 Week Range||15.93 - 29.41|
|PE Ratio (TTM)||-8.25|
|Earnings Date||Aug 3, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||36.67|
Surging implied volatility makes Flexion Therapeutics (FLXN) Stock lucrative to the option traders.
BURLINGTON, Mass., Sept. 07, 2017-- Flexion Therapeutics, Inc. today will present results from an analysis that found patients treated in clinical trials of Zilretta™, its lead candidate for the treatment ...
BURLINGTON, Mass., Aug. 30, 2017-- Flexion Therapeutics, Inc. today announced that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the ...